Current share price for REG : $6.310 0.11 (1.77%)+
Regis Healthcare Limited (REG) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is an aged care provider with over 30 years of experience, supporting more than 10,000 older Australians through Residential Aged Care, Home Care, Day Therapy, Respite Services and Retirement Villages. Having a team of over 12,000 professionals, they deliver personalized care.
| ASX Code | REG |
| Website | http://www.regis.com.au |
| Industry/Sector | Health Care Facilities |
| Market Cap ($M) | 1,907 |
| REG Share Price | $6.310 |
| Day High | $6.320 |
| Day Low | $6.170 |
| Last Close | $6.200 |
| REG Share Price Movement | $0.11 ( 1.77% ) |
As a significant Australian company by market capitalisation, REG is held across 16 ETFs spanning strategies that include health care facilities exposure . Its weighting in those funds means performance can have an outsized influence - when REG moves, funds like FSML, ALFA, MVS, M1DS and ISO that hold it can move with it.
For more concentrated exposure, ETFs such as FSML (Firetrail Australian Small Companies Fund - Active ETF) allocate about 3.4% to REG , while the average exposure across all 16 ETFs that hold it is around 0.6% .
Last updated: ETF data and holdings as at 10 August 2026
How does holding Regis Healthcare Limited (REG) shares directly compare to ETFs that include it?
|
REG Direct
|
FSML
ASX |
ALFA
ASX |
MVS
ASX |
M1DS
CBOE |
ISO
ASX |
|
|---|---|---|---|---|---|---|
| Holdings | 1 company | 10 holdings | 70 holdings | 59 holdings | 51 holdings | 198 holdings |
| REG Weight | 100% | 3.4% | 1.7% | 1.5% | 1.3% | 0.4% |
| Diversification | Single Stock | Broad | Broad | Broad | Broad | Broad |
| Annual Cost | Brokerage only | 0.85% p.a. | 0.39% p.a. | 0.49% p.a. | - | 0.55% p.a. |
| Approx. Yield | - | 5.65% | 0.87% | 2.72% | - | 4.13% |
| Star Ratings | - |
Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not REG's direct yield. Annual cost uses each ETF's MER.
How a $10,000 investment in Regis Healthcare Limited (REG) one week ago compares with ETFs that hold it.
| Security | Investment type | Current price | 7-day price movement | Dollar change | Value today |
|---|---|---|---|---|---|
| Regis Healthcare Limited (REG) | Direct share | $6.310 | 3.78% | +$378 | $10,378 |
| Firetrail Australian Small Companies Fund - Active ETF (FSML) | Equity - Australia Strategy | $2.125 | 7.05% | +$705 | $10,705 |
| Vaneck Australian Long Short Complex ETF (ALFA) | Equity - Australia Strategy | $23.060 | 2.22% | +$222 | $10,222 |
| VanEck Small Companies Masters ETF (MVS) | Equity - Australia Small/Mid Cap | $22.030 | 6.68% | +$668 | $10,668 |
| Paradice Australian Mid Cap Fund Active ETF (M1DS) | Equity - Australia Strategy | $6.430 | 6.46% | +$646 | $10,646 |
| iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) | Equity - Australia Small/Mid Cap | $5.290 | 7.09% | +$709 | $10,709 |
Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.
16 ETFs hold Regis Healthcare Limited (REG).
| ETF | REG Weight | MER | Yield |
|---|---|---|---|
| Firetrail Australian Small Companies Fund - Active ETF (FSML) | 3.4% | 0.85% | 5.65% |
| Vaneck Australian Long Short Complex ETF (ALFA) | 1.7% | 0.39% | 0.87% |
| VanEck Small Companies Masters ETF (MVS) | 1.5% | 0.49% | 2.72% |
| Paradice Australian Mid Cap Fund Active ETF (M1DS) | 1.3% | - | - |
| iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) | 0.4% | 0.55% | 4.13% |
| SPDR S&P/ASX Small Ordinaries Fund (SSO) | 0.4% | 0.5% | 8.8% |
| Milford Australian Absolute Growth Fund (Hedge Fund) (MFOA) | 0.4% | 0.9% | 14.22% |
| Vanguard MSCI Australian Small Companies Index ETF (VSO) | 0.2% | 0.3% | 4.56% |
| ishares Edge MSCI Australia Multifactor ETF (AUMF) | 0.2% | 0.3% | 2.75% |
| Global X Australia ex Financials & Resources ETF (OZXX) | 0.1% | 0.25% | 5.04% |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | 9¢ | 100% | 12 Mar 2026 | 9 Apr 2026 | - | - | - |
| HFResult | 8.13¢ | 70% | 9 Sep 2025 | 24 Sep 2025 | - | - | - |
| Result | 8.09¢ | 60% | 13 Mar 2025 | 10 Apr 2025 | - | - | - |
See all dividends from Regis Healthcare Limited (REG) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2027F | C2 | $25.20 | 31.30% | 24.60 | 22.70 | 3.70% | 0.0% |
| 2026F | C2 | $19.20 | 8.40% | 32.30 | 17.40 | 2.80% | 0.0% |
| 2025A | $53.81 | $17.70 | -676.90% | 35.10 | 16.20 | 2.60% | 65.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 A | 2026 F | 2027 F | 2025 A | 2026 F | 2027 F | 2025 A | 2026 F | 2027 F | ||
| Regis Healthcare Limited (REG) | $1,905M | -6.7687 | 0.0841 | 0.3125 | 35.5731 | 32.8125 | 25.0000 | 2.57% | 2.76% | 3.60% |
| Ramsay Health Care Limited (RHC) | $10,364M | 0.2153 | -0.2767 | 0.4017 | 28.5787 | 39.5142 | 28.1894 | 1.78% | 1.89% | 2.32% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 32.30 | -111.70 | 1.67 |
| Market | 0.31 | 13.10 | 1.15 | 0.69 |
| Sector | 0.73 | 19.20 | 1.65 | 1.92 |
| Name | Position | Start Date |
|---|---|---|
| Mr Andrew John Kinkade | Chief Executive Officer, Managing Director | 20 Jul 2026 |
| Professor Christine Constance Bennett | Non-Executive Director | 1 Mar 2018 |
| Mr Ian Gregory Roberts | Non-Executive Director | 2 May 2007 |
| Ms Jodie Lee Leonard | Non-Executive Director | 28 Nov 2023 |
| Ms Sally Margaret Freeman | Non-Executive Director | 17 Jan 2022 |
| Ms Carmel Anne Monaghan | Non-Executive Director | 1 Feb 2026 |
| Mr Graham Hodges | Non-Executive Director, Non-Executive Chairman | 25 Aug 2017 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 4 May 2026 | MELLORS, Linda | Sell | Indirect Shares | 223,950 | $6.662 | $1,491,977.200 |
| 25 Feb 2026 | MONAGHAN, Carmel | Buy | Direct Shares | 2,200 | $6.893 | $15,164.460 |
| 2 Sep 2025 | FREEMAN, Sally | Buy | Indirect Shares | 4,805 | $7.792 | $37,440.900 |
See all changes in directors' interest & trades for Regis Healthcare Limited (REG) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Name | Position |
|---|---|
| Rick Rostolis | Chief Financial Officer |
| Malcolm Peter Ross | Company Secretary,General Counsel |
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Regis Healthcare Limited (REG). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 81,910,479 (27.19%) | Galabay Pty Ltd |
| 32,205,238 (10.69%) | Ashburn Pty Ltd |
| Date | Event |
|---|---|
| 22 February 2027 | Report (Interim) |
| 24 August 2026 | Report (Annual) |
| 24 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.